World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
30428
World Ranking
11749
National Ranking
6026

Overview

Joe Y. Chang is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research mainly falls within the field of Medicine, with a focus on specialized subfields such as Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Radiation, and Surgery.

Their recent scholarly output includes multiple papers published in respected journals, reflecting ongoing contributions to lung cancer research and treatment. Notable papers include:

  • Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology (2022), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021 (2021), Journal of the National Comprehensive Cancer Network
  • Non-Small Cell Lung Cancer, Version 4.2024 (2024), Journal of the National Comprehensive Cancer Network
  • Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials (2020), The Lancet Respiratory Medicine
  • NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023 (2023), Journal of the National Comprehensive Cancer Network

Their research topics cover a broad range of cancer-related areas, including:

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Advanced Radiotherapy Techniques
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Radiation Therapy and Dosimetry

Joe Y. Chang has published extensively in several prominent journals, particularly:

  • International Journal of Radiation Oncology*Biology*Physics (30 publications)
  • Journal of Thoracic Oncology (13 publications)
  • Journal of the National Comprehensive Cancer Network (11 publications)
  • Radiotherapy and Oncology (10 publications)
  • Journal of Clinical Oncology (5 publications)

Collaboration is a significant aspect of their research activity. Frequent co-authors include Steven H. Lin, Zhongxing Liao, John V. Heymach, James W. Welsh, and Vivek Verma, indicating active engagement in multidisciplinary teams focused on lung cancer and radiation oncology.

Best Publications

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran

  • Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy.

    He Wang;Lei Dong;Jennifer O'Daniel;Radhe Mohan

  • Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

    David S. Ettinger;Douglas E. Wood;Charu Aggarwal;Dara L. Aisner

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    David S. Ettinger;David S. Ettinger;Douglas E. Wood;Douglas E. Wood;Dara L. Aisner;Wallace Akerley;Wallace Akerley

  • The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

    Kobe Reynders;Tim Illidge;Shankar Siva;Shankar Siva;Joe Y. Chang

  • Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer

    James Welsh;Ritsuko Komaki;Arya Amini;Mark F. Munsell

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

    David S. Ettinger;Dara L. Aisner;Douglas E. Wood;Wallace Akerley

  • Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

    Michael B. Bernstein;Sunil Krishnan;James W. Hodge;Joe Y. Chang

  • Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non–small-cell lung cancer

    Joe Y. Chang;Xiaodong Zhang;Xiaochun Wang;Yixiu Kang

  • A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

    Gregory M.M. Videtic;Chen Hu;Anurag K. Singh;Joe Y. Chang

  • Assessing Respiration-Induced Tumor Motion and Internal Target Volume Using Four-Dimensional Computed Tomography for Radiotherapy of Lung Cancer

    H. Helen Liu;Peter Balter;Teresa Tutt;Bum Choi

  • Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.

    Willemijn S.M.E. Theelen;Dawei Chen;Vivek Verma;Brian Paul Hobbs

  • Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non–small-cell lung cancer

    Tingyi Xia;Hongqi Li;Qingxuan Sun;Yingjie Wang

  • Intensity-Modulated Proton Therapy Reduces the Dose to Normal Tissue Compared With Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy and Enables Individualized Radical Radiotherapy for Extensive Stage IIIB Non-Small-Cell Lung Cancer: A Virtual Clinical Study

    Xiaodong Zhang;Yupeng Li;Xiaoning Pan;Li Xiaoqiang

  • Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

    Chad Tang;James W. Welsh;Patricia de Groot;Erminia Massarelli

  • Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.

    Shervin M. Shirvani;Jing Jiang;Joe Y. Chang;James W. Welsh

  • A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors.

    Vivek Verma;Tanja Sprave;Waqar M. Haque;Charles B. Simone

  • Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.

    Joe Y Chang;Peter A Balter;Lei Dong;Qiuan Yang

  • Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

    Shervin M. Shirvani;Jing Jiang;Joe Y. Chang;James Welsh

  • Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

    Gregory M. Videtic;Rebecca Paulus;Anurag K. Singh;Joe Y. Chang

Frequent Co-Authors

Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Zhongxing Liao
Zhongxing Liao The University of Texas MD Anderson Cancer Center
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Radhe Mohan
Radhe Mohan The University of Texas MD Anderson Cancer Center
Pamela K. Allen
Pamela K. Allen The University of Texas MD Anderson Cancer Center
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Xiaodong Zhang
Xiaodong Zhang The Ohio State University
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Charles Lu
Charles Lu The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Preparing for a career in medicine isn’t limited to traditional medical degrees. Many students explore alternative healthcare paths, especially through online study options. If you’re interested in nursing but wish to skip lengthy pre-admission testing, consider enrolling in a nursing school that does not require teas test. These programs offer a streamlined entry into nursing for those eager to begin caring for patients quickly.

For individuals seeking leadership positions in healthcare, accelerated healthcare programs can help you earn a degree in less time and begin advancing your career sooner. Registered Nurses looking to specialize further might be interested in rn to np bridge programs, which enable experienced nurses to transition into advanced practice roles, such as nurse practitioner.

For those with a passion for wellness, nutrition, and preventative care, there are a variety of reputable online nutrition degree programs available. These pathways offer flexibility and the opportunity to build knowledge that supports healthy communities. No matter your interests, online degree options can help you carve out a fulfilling role in the healthcare sector.

Best Scientists Citing Joe Y. Chang

Trending Scientists

Recently Published Articles